🎓 Calling All Urology Residents & Fellows! 🌍 As part of its commitment of providing opportunities for residents and fellows to advance their education, training, and professional growth, the SIU is pleased to announce that it has received a grant to subsidize registration for residents and fellows wishing to attend #SIU2025Edinburgh October 29–November 1, 2025!
See the Top 10 content on SIU Academy for the month of July, 2025
New Content available on SIU Academy. Watch the latest in the web series Advanced Urology Updates—
Reading and interpreting prostate MRI
Available only on SIU Academy—watch the webcast today!
The USANZ 78th Annual Scientific Meeting will take place in Melbourne February 28–March 3. Don’t miss this opportunity to share your research with colleagues in 2026. Deadline to submit September 1, 2025.
📢 Have New Research to Share? Submit a Late-Breaking Abstract for SIU 2025!
If your data became available after the regular abstract deadline, this is your opportunity to present your findings on a global stage. 📅 Deadline: September 3, 2025 @ 23:59 EST
ATTENTION: Unauthorized emails from third-party suppliers claiming to offer accommodation services for SIU 2025 are circulating. Find out more.
Save the Date for LUA25, the 16th Libyan Urology Association Conference and the 4th Male Infertility & Sexual Dysfunction Conference.
Happening October 9–10–11, 2025
September 2025, Urotrainer Academy offers a 5-week intensive hands-on training programme for urology residents and fellows who want to master laparoscopic partial nephrectomy.
Present Your Research at SIU 2025
For the first time, the SIU 2025 Scientific Programme Committee invites you to contribute to this year’s Congress by presenting your latest Clinical Trial in Motion. This is a unique opportunity to share your research with a global audience of urology professionals and thought leaders.
Submission Deadline: August 20 at 23:59 EDT (UTC−4)
Don’t miss your chance to be part of the SIU’s premier international scientific event. Submit your work today.
Join world-renowned experts for a dynamic programme focused on cutting-edge advances in the management of the most prevalent GU malignancies: prostate, bladder, and kidney cancers.
